March 27, 2026 C-Path’s Biomarker Data Repository March 2026 Newsletter March is National Kidney Month, making it an ideal time to highlight the progress and collaborations helping advance kidney health
March 26, 2026 BioCentury Article: Critical Path Institute Aims to Bring Scale to Individualized Medicines FDA’s plausible mechanism framework aims to accelerate and expand drug development for patients...
March 26, 2026 Critical Path Institute Launches ‘One to Millions’ to Reshape the Future of Individualized Medicine at Global Scale C-Path today announced the launch of One to Millions, a global, multi-stakeholder public-private initiative...
March 25, 2026 Closing the Gap: How Better Data Can Transform Kidney Injury Detection In July 2024, I accepted a data manager position within Critical Path Institute’s Data Collaboration Center, unaware...
March 24, 2026 C-Path Taps Veteran Health Technology Leader to Drive Data and AI Strategy as Chief Data and Technology Officer C-Path today announced the appointment of Christopher Lunt as its Chief Data and Technology Officer.
March 23, 2026 Critical Path Institute and Collaborators Honored with Society of Toxicology Science Paper of the Year Award TUCSON, Ariz., March 23, 2026 — Critical Path Institute® (C-Path) announced today that the Society of Toxicology (SOT)...
March 17, 2026 C-Path Biomarker Repository Co-Chair Glenda Roberts Honored with 2026 Derek Forfang Patient Advocate Award C-Path is eager to celebrate the recognition of its Biomarker Data Repository Co-chair Glenda Roberts...
March 17, 2026 PBC Ireland Partners with C-Path’s Rare Disease Data Platform, Advancing Research Efforts for Primary Biliary Cholangitis TUCSON, Ariz., March 12, 2026 — In a significant step to enhance research efforts for Primary Biliary Cholangitis...
March 10, 2026 New Study on Early Parkinson’s Disease Progression Highlights Vital Role of Patient Focused Drug Development and Real-World Impacts TUCSON, Ariz., March 5, 2026 – Critical Path Institute® (C-Path) applauds the publication of a new study in the Journal of...
March 3, 2026 Critical Path Institute’s Translational Therapeutics Accelerator Awards Grant to Support Development of Novel Nonopioid Pain Therapeutics TUCSON, Ariz., March 3, 2026 — Critical Path Institute’s® (C-Path) Bridging Research and Innovation in Drug Development...